Applied DNA Sciences (NASDAQ:APDN)報告季度每股虧損$(0.56)，未達到分析師一致預期的$(0.28)，相差100%。這比去年同期每股虧損$(0.09)減少了522.22%。公司報告季度銷售額爲$1.20百萬，超出分析師一致預期的$1.10百萬，超出8.67%。這比去年同期的銷售額$891.16千增加了34.32%。

以上內容來自Benzinga Earnings專欄，原文如下：

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.28) by 100 percent. This is a 522.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $1.20 million which beat the analyst consensus estimate of $1.10 million by 8.67 percent. This is a 34.32 percent increase over sales of $891.16 thousand the same period last year.